Epifinder, Inc.
  1. Companies
  2. Epifinder, Inc.
  3. Software
  4. Epifinder - Clinical Screening Tool

EpifinderClinical Screening Tool

SHARE

EpiFinder’s Clinical Screening Tool collects symptoms and maps it to our evidence-based algorithm, which provides the most likely differential diagnoses of epilepsy and decreases the rate of misdiagnosis.

Most popular related searches

Our questionnaire lets patients fill out their preliminary information and symptoms ahead of their appointment time on the go or from the comfort of their home.

After reviewing symptoms at a glance, doctors can focus on the missing details of the epileptic event. This gives you more time to explore the story together and find the root cause.
Through our diagnostic tool, we screen the information with evidence-based data. Our app gives doctors the most likely differential diagnoses of epilepsy seizures and syndromes. It’s here to help you with further exploration and treatment.

Clinical

  • Improved patient-provider communication
  • Assistance in differential epilepsy diagnoses
  • Clinical summary of patient symptoms
  • Standardized ILAE terms
  • Training in epilepsy assessment
Operational
  • Improved workflow
  • Increased quality of doctor-patient interaction
  • HIPAA compliant
  • Interactive user interface
Financial
  • Saves time + more patient visits

We are a healthcare software solutions and neuro-spectrum differentiation company that strives to increase diagnostic accuracy in epilepsy, standardize care and screening practices, and improve the quality of life for epilepsy patients.

Epilepsy – Overlooked & Underfunded Globally
Epilepsy is a neurologic disorder causing uncontrollable seizure episodes. Over 65 million people live with the condition, and there are 62 different epilepsy syndromes. Timely and accurate information is critical for correctly diagnosing epilepsy. Effective management and treatment can help patients to take control of their lives.

  • 65M People with epilepsy
  • 62 Types of epilepsy
  • 40% Misdiagnosed
  • 40% Treatment non-compliance
  • 18mos. to see a specialist
  • 5 yrs Evaluation gap

Diagnosing epilepsy is a long journey with many wrong turns and misdirections. Patients can undergo months of testing and still have unanswered questions. This results in patients waiting for 18 months to see a specialist and enduring a treatment gap of 5 or more years.

EpiFinder provides a screening and diagnostic tool to assist in distinguishing between the 62 specific types of epilepsy. We also offer a behavioral self-management tool to improve patient compliance in treatment through the use of interactive features and ease of use.